• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有酸性pH值和组织蛋白酶B的脂质体的溶酶体靶向作用可诱导蛋白质聚集体清除。

Lysosomal targeting of liposomes with acidic pH and Cathepsin B induces protein aggregate clearance.

作者信息

Jeon Minsol, Kim Da-Eun, Choi So Young, Kim Seoyoung, Kim Seongchan, Lee Hyojin, Kim Hyunkyung

机构信息

Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, 02841, Republic of Korea.

BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul, 02841, Republic of Korea.

出版信息

Cell Commun Signal. 2025 Jun 19;23(1):296. doi: 10.1186/s12964-025-02310-z.

DOI:10.1186/s12964-025-02310-z
PMID:40537797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12180193/
Abstract

The autophagy-lysosomal pathway is a cellular degradation mechanism that regulates protein quality by eliminating aggregates and maintaining normal protein function. It has been reported that aging itself reduces lysosomal proteolytic activity in age-related neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Reduction in lysosomal function may underlie the accumulation of protein aggregates such as amyloid beta (Aβ), tau, and α-synuclein. Some of these protein aggregates may cause additional lysosomal dysfunction and create a vicious cycle leading to a gradual increase in protein aggregation. In this study, liposome-based lysosomal pH-modulating particles (LPPs), containing a liquid solution to adjust lysosomal pH, have been developed to restore lysosomal function. The results demonstrate that acidic LPPs effectively restore lysosomal function by recovering lysosomal pH and facilitating the removal of protein aggregates. These findings demonstrated that acidic LPPs could effectively recover the abnormal lysosomal function via restoration of lysosomal pH and enhance the clearance of protein aggregates. Furthermore, the simultaneous introduction of Cathepsin B (CTSB) proteins and acidic LPP revealed a synergistic effect, promoting lysosomal pH recovery and enhancing aggregates removal. These findings suggest a novel strategy for improving lysosomal clearance activity in proteinopathies.

摘要

自噬-溶酶体途径是一种细胞降解机制,通过清除聚集体和维持正常蛋白质功能来调节蛋白质质量。据报道,在阿尔茨海默病和帕金森病等与年龄相关的神经退行性疾病中,衰老本身会降低溶酶体的蛋白水解活性。溶酶体功能的降低可能是淀粉样β蛋白(Aβ)、tau蛋白和α-突触核蛋白等蛋白质聚集体积累的基础。其中一些蛋白质聚集体可能会导致额外的溶酶体功能障碍,并形成恶性循环,导致蛋白质聚集逐渐增加。在本研究中,已开发出基于脂质体的溶酶体pH调节颗粒(LPPs),其含有用于调节溶酶体pH的液体溶液,以恢复溶酶体功能。结果表明,酸性LPPs通过恢复溶酶体pH值和促进蛋白质聚集体的清除,有效地恢复了溶酶体功能。这些发现表明,酸性LPPs可以通过恢复溶酶体pH值有效地恢复异常的溶酶体功能,并增强蛋白质聚集体的清除。此外,同时引入组织蛋白酶B(CTSB)蛋白和酸性LPP显示出协同效应,促进溶酶体pH值恢复并增强聚集体清除。这些发现提示了一种改善蛋白质病中溶酶体清除活性的新策略。

相似文献

1
Lysosomal targeting of liposomes with acidic pH and Cathepsin B induces protein aggregate clearance.具有酸性pH值和组织蛋白酶B的脂质体的溶酶体靶向作用可诱导蛋白质聚集体清除。
Cell Commun Signal. 2025 Jun 19;23(1):296. doi: 10.1186/s12964-025-02310-z.
2
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
3
Autophagy-lysosomal-associated neuronal death in neurodegenerative disease.自噬溶酶体相关神经元死亡在神经退行性疾病中的作用。
Acta Neuropathol. 2024 Sep 11;148(1):42. doi: 10.1007/s00401-024-02799-7.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Experiences of patients with lysosomal storage disorders who are receiving enzyme-replacement therapy and the experiences of their family members: a qualitative systematic review.接受酶替代疗法的溶酶体贮积症患者及其家属的体验:定性系统评价。
JBI Evid Synth. 2022 Jun 1;20(6):1474-1510. doi: 10.11124/JBIES-21-00074.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Non-invasive ventilation for cystic fibrosis.囊性纤维化的无创通气
Cochrane Database Syst Rev. 2017 Feb 20;2(2):CD002769. doi: 10.1002/14651858.CD002769.pub5.
8
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
9
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
10
Single-incision sling operations for urinary incontinence in women.女性尿失禁的单切口吊带手术
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD008709. doi: 10.1002/14651858.CD008709.pub3.

本文引用的文献

1
Golgi pH homeostasis stabilizes the lysosomal membrane through -glycosylation of membrane proteins.高尔基体内 pH 平衡通过糖基化修饰稳定溶酶体膜上的膜蛋白。
Life Sci Alliance. 2024 Jul 30;7(10). doi: 10.26508/lsa.202402677. Print 2024 Oct.
2
Activation of Lysosomal Function Ameliorates Amyloid-β-Induced Tight Junction Disruption in the Retinal Pigment Epithelium.溶酶体功能的激活可改善视网膜色素上皮细胞中淀粉样β诱导的紧密连接破坏。
Mol Cells. 2023 Nov 30;46(11):675-687. doi: 10.14348/molcells.2023.0056. Epub 2023 Nov 8.
3
Characterization of Uranyl (UO) Ion Binding to Amyloid Beta (Aβ) Peptides: Effects on Aβ Structure and Aggregation.
铀酰(UO)离子与淀粉样β(Aβ)肽的相互作用特征:对 Aβ结构和聚集的影响。
ACS Chem Neurosci. 2023 Aug 2;14(15):2618-2633. doi: 10.1021/acschemneuro.3c00130. Epub 2023 Jul 24.
4
Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery.纳米药物递送中克服内体/溶酶体屏障的先进策略
Research (Wash D C). 2023 May 24;6:0148. doi: 10.34133/research.0148. eCollection 2023.
5
Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer's Drugs.药物递送系统作为提高美国食品药品监督管理局(FDA)批准的阿尔茨海默病药物疗效的一种策略。
Pharmaceutics. 2022 Oct 26;14(11):2296. doi: 10.3390/pharmaceutics14112296.
6
Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies.社论:神经退行性蛋白质病的作用机制
Front Neurosci. 2022 Jun 30;16:968994. doi: 10.3389/fnins.2022.968994. eCollection 2022.
7
The role of lipid components in lipid nanoparticles for vaccines and gene therapy.脂质成分在疫苗和基因治疗用脂质纳米粒中的作用。
Adv Drug Deliv Rev. 2022 Sep;188:114416. doi: 10.1016/j.addr.2022.114416. Epub 2022 Jul 3.
8
The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system.AUTOTAC 化学生物学平台通过自噬溶酶体系统实现靶向蛋白降解。
Nat Commun. 2022 Feb 16;13(1):904. doi: 10.1038/s41467-022-28520-4.
9
Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity.淀粉样聚集蛋白通过获得功能毒性导致神经元溶酶体缺陷。
Life Sci Alliance. 2021 Dec 21;5(3). doi: 10.26508/lsa.202101185. Print 2022 Mar.
10
Membrane channel hypothesis of lysosomal permeabilization by beta-amyloid.β-淀粉样蛋白导致溶酶体通透性改变的膜通道假说。
Neurosci Lett. 2022 Jan 23;770:136338. doi: 10.1016/j.neulet.2021.136338. Epub 2021 Nov 9.